GLUE
Monte Rosa Therapeutics, Inc.Company with tickers: GLUE
CIK
1826457
Shares Outstanding
80,015,667
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-04 | Dunn Edmund | Principal Accounting Officer | Sell | 139 |
| 2026-03-02 | Warmuth Markus | Director, President & CEO | Sell | 5,466 |
| 2026-03-02 | Dunn Edmund | Principal Accounting Officer | Convert | 536 |
| 2026-03-02 | Dunn Edmund | Principal Accounting Officer | Sell | 536 |
| 2026-03-02 | Dunn Edmund | Principal Accounting Officer | Convert | 536 |
| 2026-02-27 | Dunn Edmund | Principal Accounting Officer | Convert | 25,164 |
| 2026-02-27 | Dunn Edmund | Principal Accounting Officer | Sell | 25,164 |
| 2026-02-27 | Dunn Edmund | Principal Accounting Officer | Convert | 25,164 |
| 2026-02-23 | Janku Filip | Chief Medical Officer | Sell | 9,189 |
| 2026-01-07 | Warmuth Markus | Director, President & CEO | Sell | 3,707 |
| 2026-01-05 | Nickson Philip | Chief Business & Legal Officer | Sell | 3,155 |
| 2026-01-05 | Champoux Jennifer | Chief Operating Officer | Sell | 2,629 |
| 2026-01-05 | Warmuth Markus | Director, President & CEO | Sell | 10,135 |
| 2026-01-05 | Janku Filip | Chief Medical Officer | Sell | 3,155 |
| 2026-01-05 | Townson Sharon | Chief Scientific Officer | Sell | 3,155 |
| 2026-01-05 | Dunn Edmund | Principal Accounting Officer | Sell | 1,039 |
| 2026-01-02 | Nickson Philip | Chief Business & Legal Officer | Award | 28,000 |
| 2026-01-02 | Nickson Philip | Chief Business & Legal Officer | Award | 126,000 |
| 2026-01-02 | Champoux Jennifer | Chief Operating Officer | Award | 158,000 |
| 2026-01-02 | Champoux Jennifer | Chief Operating Officer | Award | 35,000 |
| 2026-01-02 | Warmuth Markus | Director, President & CEO | Award | 90,000 |
| 2026-01-02 | Warmuth Markus | Director, President & CEO | Award | 406,000 |
| 2026-01-02 | Janku Filip | Chief Medical Officer | Award | 31,000 |
| 2026-01-02 | Janku Filip | Chief Medical Officer | Award | 139,000 |
| 2026-01-02 | Townson Sharon | Chief Scientific Officer | Award | 35,000 |
| 2026-01-02 | Townson Sharon | Chief Scientific Officer | Award | 158,000 |
| 2025-06-13 | Skvarka Jan | Director | Award | 30,700 |
| 2025-06-13 | SCHIFF ANDREW N | Director | Award | 30,700 |
| 2025-06-13 | Behbahani Ali | Director, 10% Owner | Award | 30,700 |
| 2025-06-13 | Hughes Eric A | See "Remarks" | Award | 30,700 |
| 2025-06-13 | Manning Anthony M. | Director | Award | 30,700 |
| 2025-06-13 | Blackwell Kimberly | Director | Award | 30,700 |
| 2025-06-13 | Siu Christine | Director | Award | 30,700 |
| 2025-06-03 | Dunn Edmund | Principal Accounting Officer | Sell | 2,062 |
| 2025-03-24 | Leo Chandra P. | Director | Buy | 10,000 |
| 2025-01-02 | Dunn Edmund | Principal Accounting Officer | Award | 11,850 |
| 2025-01-02 | Dunn Edmund | Principal Accounting Officer | Award | 53,400 |
| 2025-01-02 | Janku Filip | Chief Medical Officer | Award | 36,000 |
| 2025-01-02 | Janku Filip | Chief Medical Officer | Award | 161,000 |
| 2025-01-02 | Warmuth Markus | Director, President & CEO | Award | 128,000 |
| 2025-01-02 | Warmuth Markus | Director, President & CEO | Award | 575,000 |
| 2025-01-02 | Nickson Philip | Chief Business & Legal Officer | Award | 36,000 |
| 2025-01-02 | Nickson Philip | Chief Business & Legal Officer | Award | 161,000 |
| 2025-01-02 | Champoux Jennifer | Chief Operating Officer | Award | 135,000 |
| 2025-01-02 | Champoux Jennifer | Chief Operating Officer | Award | 30,000 |
| 2025-01-02 | Townson Sharon | Chief Scientific Officer | Award | 161,000 |
| 2025-01-02 | Townson Sharon | Chief Scientific Officer | Award | 36,000 |
| 2024-12-11 | Hughes Eric A | See "Remarks" | Award | 44,200 |
| 2024-12-11 | Hughes Eric A | See "Remarks" | Other | 0 |
| 2024-10-29 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 52,305 |
| 2024-10-28 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 89,990 |
| 2024-10-28 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 1,019,867 |
| 2024-09-20 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 1,132,566 |
| 2024-09-20 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 2,097,938 |
| 2024-09-13 | Janku Filip | Chief Medical Officer | Award | 30,000 |
| 2024-09-13 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 9,269 |
| 2024-09-12 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 16,047 |
| 2024-09-11 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 541,897 |
| 2024-09-11 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 2,097,938 |
| 2024-07-05 | Dunn Edmund | Principal Accounting Officer | Sell | 1,610 |
| 2024-06-12 | Behbahani Ali | Director, 10% Owner | Award | 22,100 |
| 2024-06-12 | Siu Christine | Director | Award | 22,100 |
| 2024-06-12 | Manning Anthony M. | Director | Award | 22,100 |
| 2024-06-12 | SCHIFF ANDREW N | Director | Award | 22,100 |
| 2024-06-12 | Skvarka Jan | Director | Award | 22,100 |
| 2024-06-12 | Blackwell Kimberly | Director | Award | 22,100 |
| 2024-06-03 | Champoux Jennifer | Chief Operating Officer | Award | 40,000 |
| 2024-06-03 | Townson Sharon | Chief Scientific Officer | Award | 40,000 |
| 2024-06-03 | Nickson Philip | Chief Business & Legal Officer | Award | 40,000 |
| 2024-06-03 | Dunn Edmund | Principal Accounting Officer | Sell | 1,207 |
| 2024-05-28 | Champoux Jennifer | Chief Operating Officer | Other | 0 |
| 2024-05-28 | Townson Sharon | Chief Scientific Officer | Other | 0 |
| 2024-01-02 | Janku Filip | Chief Medical Officer | Other | 5,252 |
| 2024-01-02 | Janku Filip | Chief Medical Officer | Award | 121,000 |
| 2024-01-02 | Dunn Edmund | Principal Accounting Officer | Award | 25,000 |
| 2024-01-02 | Warmuth Markus | Director, President & CEO | Award | 346,000 |
| 2024-01-02 | Wallace Owen B. | Chief Scientific Officer | Award | 119,000 |
| 2024-01-02 | Wallace Owen B. | Chief Scientific Officer | Other | 5,266 |
| 2024-01-02 | Jones Jullian G | Chief Business Officer | Award | 79,000 |
| 2024-01-02 | Nickson Philip | Chief Business & Legal Officer | Award | 109,000 |
| 2023-08-08 | Dunn Edmund | Principal Accounting Officer | Other | 16,761 |
| 2023-08-08 | Dunn Edmund | Principal Accounting Officer | Other | 0 |
| 2023-07-25 | Manning Anthony M. | Director | Award | 41,000 |
| 2023-07-25 | Manning Anthony M. | Director | Other | 0 |
| 2023-06-14 | SCHIFF ANDREW N | Director | Award | 20,500 |
| 2023-06-14 | Mayweg Alexander | Director | Award | 20,500 |
| 2023-06-14 | Behbahani Ali | Director, 10% Owner | Award | 20,500 |
| 2023-06-14 | Siu Christine | Director | Award | 20,500 |
| 2023-06-14 | Blackwell Kimberly | Director | Award | 20,500 |
| 2023-06-14 | Skvarka Jan | Director | Award | 20,500 |
| 2023-03-30 | Skvarka Jan | Director | Award | 41,000 |
| 2023-03-23 | Skvarka Jan | Director | Other | 0 |
| 2023-01-03 | Warmuth Markus | Director, President & CEO | Award | 472,000 |
| 2023-01-03 | Townson Sharon | Chief Scientific Officer | Award | 78,550 |
| 2023-01-03 | Janku Filip | Chief Medical Officer | Award | 135,000 |
| 2023-01-03 | Jones Jullian G | Chief Business Officer | Award | 77,450 |
| 2023-01-03 | Castle John C. | Chief Data Scientist | Award | 78,500 |
| 2023-01-03 | Wallace Owen B. | Chief Scientific Officer | Award | 135,000 |
| 2023-01-03 | Nickson Philip | Chief Business & Legal Officer | Award | 123,650 |
| 2023-01-03 | Tamboli Ajim | Chief Financial Officer | Award | 129,850 |